EMV Capital
EMV Capital plc is a leading deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. They invest in, manage, and strengthen early-stage IP-rich companies with a focus on generating superior returns for investors. EMV Capital employs a proactive management style, aiming to advance companies to critical value inflection points.
📥 Buy Full VC Dataset
Offices: London (United Kingdom), Cambridge (United Kingdom)
Investment Stages: Seed, Pre-Series A, Series A, Series B
Markets: Deep Tech, Life Sciences, Sustainability, Industrials, Robotics, AI
Founded Year: 2018
Investor Type: Venture Capital
Portfolio Companies: AI VIVO, AllFocal Optics, Axol Bioscience, Beam, Cambridge GaN Devices, Cambridge Nutraceuticals, Camstent, Cetromed, Closed Loop Medicine, Converge, Cytovale, DeepTech Recycling, Dname-iT, Dogtooth Technologies, Echion Technologies, EpiBone, Exonate, FocalPoint Positioning, FOx Biosystems, G-Tech Medical, Glycotest, IESO Digital Health, Infinitopes, Kalium Health, Lungfish, Myrtle.ai, Nanotech Industrial Solutions, NoBACZ, NU Quantum, NunaBio, OctaiPipe, Oncocidia, Oxford Space Systems, Paragraf, PatientSource, PDS Biotechnology, Pencil Biosciences, PervasID, PharmEnable, Plastometrex, Plumis, PointGrab, Porotech, ProAxsis, Psyomics, Q-Bot, Qkine, QuantalX Neuroscience, RoboK, SageTech Medical, Semarion, Signaloid, Sofant Technologies, Sorex Sensors, Spotta, Strolll, Techspert, Transparent Choice, Tripism, Undo, Ventive, Vortex, Wanda Health, Xampla
Website: https://emvcapital.com
Team Page: https://emvcapital.com/about/team/
Portfolio Link: https://emvcapital.com/portfolio/
Comments
No comments yet. Be the first to comment!